Background This multicentre cohort study sought to define a robust pathological indicator of clinically meaningful response to neoadjuvant chemotherapy in oesophageal adenocarcinoma. Methods A questionnaire was distributed to 11 UK upper gastrointestinal cancer centres to determine the use of assessment of response to neoadjuvant chemotherapy. Records of consecutive patients undergoing oesophagogastric resection at seven centres between January 2000 and Dece... Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- John Wiley & Sons Ltd Publisher's website
- British Journal of Surgery Journal website
- Publication date:
- Acceptance date:
- Pubs id:
- Local pid:
- Copyright holder:
- Noble et al.
- Copyright date:
Copyright © 2017 The Authors. BJS published by John Wiley & Sons Ltd on behalf of BJS Society Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma
National Institute for Health Research Cambridge Biomedical Research Centre More from this funder
Experimental Cancer Medicine Centre More from this funder